Fortrea Holdings (FTRE) Other financing activities (2022 - 2023)
Fortrea Holdings' (FTRE) quarterly Other financing activities came in at -$159.9 million in Q2 2023, down 752.65% on a QoQ basis from $24.5 million in Q1 2023.
Fortrea Holdings (FTRE) Other financing activities (2022 - 2023) Analysis & Trends
Fortrea Holdings (FTRE) has 2 years of Other financing activities data on file, last reported at -$159.9 million in Q2 2023.
- Quarterly Other financing activities changed N/A year-over-year to -$159.9 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was -$159.9 million (changed N/A YoY) and the FY2023 annual result came in at -$135.4 million, down 2049.21% from the prior year.
- Other financing activities fell to -$159.9 million in Q2 2023, from $24.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $24.5 million in Q1 2023 to a low of -$159.9 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -159.90 Mn |
| Jun 30, 2023 | -159.90 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Mar 31, 2023 | 24.50 Mn |
| Dec 31, 2022 | -5.90 Mn |
| Dec 31, 2022 | -5.90 Mn |
| Sep 30, 2022 | -46.50 Mn |
| Sep 30, 2022 | -46.50 Mn |